Evidence map›Paper›PMID 25469381›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2014

Hypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesity.

David Aguilar, Maria Luz Fernandez

Open access · bronzeAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Food & nutrition research · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effect ofJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Review
  10. Wax apple (Journal of traditional and complementary medicine · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. High fat high sucrose diet-induced dyslipidemia in guinea pigs.Journal of applied physiology (Bethesda, Md. : 1985) · 2021
    Article
  18. Pharmaceutical biology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David Aguilar
Maria Luz Fernandez
University of Connecticut · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well known that hypercholesterolemia can lead to atherosclerosis and coronary heart disease. Adipose tissue represents an active endocrine and metabolic site, which might be involved in the development of chronic disease. Because adipose tissue is a key site for cholesterol metabolism and the presence of hypercholesterolemia has been shown to induce adipocyte cholesterol overload, it is critical to investigate the role of hypercholesterolemia on normal adipose function. Studies in preadipocytes revealed that cholesterol accumulation can impair adipocyte differentiation and maturation by affecting multiple transcription factors. Hypercholesterolemia has been observed to cause adipocyte hypertrophy, adipose tissue inflammation, and disruption of endocrine function in animal studies. Moreover, these effects can also be observed in obesity-independent conditions as confirmed by clinical trials. In humans, hypercholesterolemia disrupts adipose hormone secretion of visfatin, leptin, and adiponectin, adipokines that play a central role in numerous metabolic pathways and regulate basic physiologic responses such as appetite and satiety. Remarkably, treatment with cholesterol-lowering drugs has been shown to restore adipose tissue endocrine function. In this review the role of hypercholesterolemia on adipose tissue differentiation and maturation, as well as on hormone secretion and physiologic outcomes, in obesity and non–obesity conditions is presented.

Indexed as

AdipocytesAdiponectinAdipose TissueAdiposityAnimalsAnticholesteremic AgentsCell DifferentiationClinical Trials as TopicDisease Models, AnimalHumansHypercholesterolemiaInflammationLeptinNicotinamide PhosphoribosyltransferaseObesityAdiponectinAnticholesteremic AgentsLeptinNicotinamide Phosphoribosyltransferase

Identifiers

PMID25469381
PMCPMC4188221
OpenAlexW2092633555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.